Is Bon Natural Life Limited Ordinary Shares a good investment? Bon Natural Life Limited Ordinary Shares (BON) is currently trading at 1.29 USD.
In terms of valuation, the stock trades at a P/E ratio of 0.08. This relatively low multiple may signal that Bon Natural Life Limited Ordinary Shares is undervalued compared to historical market norms.
Earnings Schedule: Bon Natural Life Limited Ordinary Shares is expected to release its next earnings report on June 3, 2026. The market consensus estimate for Forward EPS is 0.58.
No, it does not currently pay a dividend.
Bon Natural Life Limited Ordinary Shares is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be June 3, 2026. The company currently has a trailing EPS of -0.72.
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. It sells its products through direct distributors. The company serves manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company has a strategic partnership with Tigerbone Group Limited. Bon Natural Life Limited was founded in 2006 and is headquartered in Xi'an, the People's Republic of China.
| Split Date | Split Ratio to 1 |
|---|---|
| May 19, 2025 | 0.040000 |
| April 11, 2024 | 0.100000 |
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion